WallStreetZenWallStreetZen

NASDAQ: AXDX
Accelerate Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AXDX stock forecasts and price targets.

Forecast return on equity

Is AXDX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is AXDX forecast to generate an efficient return on assets?

Company
-176.57%
Industry
9.52%
AXDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AXDX earnings per share forecast

What is AXDX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.00

AXDX revenue forecast

What is AXDX's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$12.3M+5.15%

AXDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AXDX$0.57N/AN/A
IINN$0.58N/AN/A
BSGM$0.57$2.50+338.60%Buy
ALUR$2.29$9.25+303.93%Buy
VVOS$2.30$6.10+165.22%Strong Buy
View Top Medical Device Stocks

Accelerate Diagnostics Stock Forecast FAQ

What is AXDX's earnings growth forecast for 2025-2025?

(NASDAQ: AXDX) Accelerate Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Accelerate Diagnostics's earnings in 2025 is -$50,045,000.

In 2025, AXDX is forecast to generate -$50,420,784 in earnings, with the lowest earnings forecast at -$50,420,784 and the highest earnings forecast at -$50,420,784.

If you're new to stock investing, here's how to buy Accelerate Diagnostics stock.

What is AXDX's revenue growth forecast for 2025-2025?

(NASDAQ: AXDX) Accelerate Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Accelerate Diagnostics's revenue in 2025 is $11,698,000.

In 2025, AXDX is forecast to generate $310,087,822 in revenue, with the lowest revenue forecast at $310,087,822 and the highest revenue forecast at $310,087,822.

What is AXDX's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: AXDX) forecast ROA is -176.57%, which is lower than the forecast US Medical Devices industry average of 9.52%.

What is AXDX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: AXDX) Accelerate Diagnostics's current Earnings Per Share (EPS) is -$2.15. In 2025, AXDX's EPS is forecast to hit -$2.00 (min: -$2.00, max: -$2.00).

What is AXDX's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: AXDX) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.